{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:37:28Z","timestamp":1786628248461,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48498-z","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:34:54Z","timestamp":1777034094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mathematical modelling of premature haematopoietic ageing in dyskeratosis congenita"],"prefix":"10.1038","volume":"16","author":[{"given":"Ana M.","family":"Portillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Garc\u00eda-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"48498_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature10084","volume":"474","author":"LF Batista","year":"2011","unstructured":"Batista, L. F. et al. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 474, 399\u2013402 (2011).","journal-title":"Nature"},{"key":"48498_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.biochi.2007.07.017","volume":"90","author":"T Vulliamy","year":"2008","unstructured":"Vulliamy, T. & Dokal, I. Dyskeratosis congenita: The diverse clinical presentation of mutations in the telomerase complex. Biochimie 90, 122\u2013130 (2008).","journal-title":"Biochimie"},{"key":"48498_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13256-025-05031-6","volume":"19","author":"G Yu","year":"2025","unstructured":"Yu, G. et al. Tert de novo mutation-associated dyskeratosis congenita and porto-sinusoidal vascular disease: A case report. Journal of Medical Case Reports 19, 32 (2025).","journal-title":"Journal of Medical Case Reports"},{"key":"48498_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/17474086.2022.2108784","volume":"15","author":"H Tummala","year":"2022","unstructured":"Tummala, H., Walne, A. & Dokal, I. The biology and management of dyskeratosis congenita and related disorders of telomeres. Expert review of hematology 15, 685\u2013696 (2022).","journal-title":"Expert review of hematology"},{"key":"48498_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1182\/hematology.2022000394","volume":"2022","author":"SA Savage","year":"2022","unstructured":"Savage, S. A. Dyskeratosis congenita and telomere biology disorders. Hematology 2022, 637\u2013648 (2022).","journal-title":"Hematology"},{"key":"48498_CR6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1172\/JCI66370","volume":"123","author":"M Armanios","year":"2013","unstructured":"Armanios, M. Telomeres and age-related disease: How telomere biology informs clinical paradigms. Journal of Clinical Investigation 123, 996\u20131002 (2013).","journal-title":"Journal of Clinical Investigation"},{"key":"48498_CR7","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/humu.22397","volume":"34","author":"JK Alder","year":"2013","unstructured":"Alder, J. K. et al. Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (dkc 1) gene. Human mutation 34, 1481\u20131485 (2013).","journal-title":"Human mutation"},{"key":"48498_CR8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrg3246","volume":"13","author":"M Armanios","year":"2012","unstructured":"Armanios, M. & Blackburn, E. H. The telomere syndromes. Nature Reviews Genetics 13, 693\u2013704 (2012).","journal-title":"Nature Reviews Genetics"},{"key":"48498_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/33345","volume":"392","author":"H-W Lee","year":"1998","unstructured":"Lee, H.-W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569\u2013574 (1998).","journal-title":"Nature"},{"key":"48498_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","volume":"12","author":"MR Niewisch","year":"2019","unstructured":"Niewisch, M. R. & Savage, S. A. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev. Hematol. 12, 1037\u20131052 (2019).","journal-title":"Expert Rev. Hematol."},{"key":"48498_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/ejhg.2014.170","volume":"23","author":"I Dokal","year":"2015","unstructured":"Dokal, I., Vulliamy, T., Mason, P. & Bessler, M. Clinical utility gene card for: Dyskeratosis congenita-update 2015. Eur. J. Hum. Genet. 23, 558\u2013558 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"48498_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0092-8674(82)90109-X","volume":"29","author":"JW Szostak","year":"1982","unstructured":"Szostak, J. W. & Blackburn, E. H. Cloning yeast telomeres on linear plasmid vectors. Cell 29, 245\u2013255 (1982).","journal-title":"Cell"},{"key":"48498_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/310154a0","volume":"310","author":"J Shampay","year":"1984","unstructured":"Shampay, J., Szostak, J. W. & Blackburn, E. H. DNA sequences of telomeres maintained in yeast. Nature 310, 154\u2013157 (1984).","journal-title":"Nature"},{"key":"48498_CR14","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1126\/science.aab3389","volume":"350","author":"EH Blackburn","year":"2015","unstructured":"Blackburn, E. H., Epel, E. S. & Lin, J. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science 350, 1193\u20131198 (2015).","journal-title":"Science"},{"key":"48498_CR15","doi-asserted-by":"crossref","unstructured":"de Lange, T. How shelterin orchestrates the replication and protection of telomeres. Cold Spring Harbor Perspectives in Biology a041685 (2025).","DOI":"10.1101\/cshperspect.a041685"},{"key":"48498_CR16","first-page":"561","volume":"93","author":"AM Polonio","year":"2020","unstructured":"Polonio, A. M. et al. Focus: Sex & reproduction: Impact of ovarian aging in reproduction: From telomeres and mice models to ovarian rejuvenation. The Yale journal of biology and medicine 93, 561 (2020).","journal-title":"The Yale journal of biology and medicine"},{"key":"48498_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2021.111541","volume":"198","author":"L Chico-Sordo","year":"2021","unstructured":"Chico-Sordo, L. et al. Reproductive aging and telomeres: Are women and men equally affected?. Mech. Ageing Dev. 198, 111541 (2021).","journal-title":"Mech. Ageing Dev."},{"key":"48498_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/345458a0","volume":"345","author":"CB Harley","year":"1990","unstructured":"Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458\u2013460 (1990).","journal-title":"Nature"},{"key":"48498_CR19","first-page":"876","volume":"55","author":"PE Slagboom","year":"1994","unstructured":"Slagboom, P. E., Droog, S. & Boomsma, D. I. Genetic determination of telomere size in humans: a twin study of three age groups. American journal of human genetics 55, 876 (1994).","journal-title":"American journal of human genetics"},{"key":"48498_CR20","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/346866a0","volume":"346","author":"ND Hastie","year":"1990","unstructured":"Hastie, N. D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866\u2013868 (1990).","journal-title":"Nature"},{"key":"48498_CR21","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1073\/pnas.0609367104","volume":"104","author":"A Canela","year":"2007","unstructured":"Canela, A., Vera, E., Klatt, P. & Blasco, M. A. High-throughput telomere length quantification by fish and its application to human population studies. Proc. Natl. Acad. Sci. U. S. A. 104, 5300\u20135305 (2007).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"48498_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0022-5193(73)90198-7","volume":"41","author":"AM Olovnikov","year":"1973","unstructured":"Olovnikov, A. M. A theory of marginotomy: the incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. Journal of theoretical biology 41, 181\u2013190 (1973).","journal-title":"Journal of theoretical biology"},{"key":"48498_CR23","first-page":"394","volume":"201","author":"A Olovnikov","year":"1971","unstructured":"Olovnikov, A. Principle of marginotomy in template synthesis of polynucleotides. In Dokl Biochem 201, 394\u2013397 (1971).","journal-title":"In Dokl Biochem"},{"key":"48498_CR24","doi-asserted-by":"publisher","first-page":"10114","DOI":"10.1073\/pnas.89.21.10114","volume":"89","author":"RC Allsopp","year":"1992","unstructured":"Allsopp, R. C. et al. Telomere length predicts replicative capacity of human fibroblasts. Proceedings of the National Academy of Sciences 89, 10114\u201310118 (1992).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"48498_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","volume":"25","author":"L Hayflick","year":"1961","unstructured":"Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Experimental cell research 25, 585\u2013621 (1961).","journal-title":"Experimental cell research"},{"key":"48498_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0092-8674(85)90170-9","volume":"43","author":"CW Greider","year":"1985","unstructured":"Greider, C. W. & Blackburn, E. H. Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell 43, 405\u2013413 (1985).","journal-title":"Cell"},{"key":"48498_CR27","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101208","author":"JV Graniel","year":"2022","unstructured":"Graniel, J. V. et al. Differential impact of a dyskeratosis congenita mutation in tpp1 on mouse hematopoiesis and germline. Life Sci. Alliance https:\/\/doi.org\/10.26508\/lsa.202101208 (2022).","journal-title":"Life Sci. Alliance"},{"key":"48498_CR28","doi-asserted-by":"crossref","unstructured":"He, J. et al. Variable expression of dkc1 mutations in mice. Genesis 47, 366\u2013373 (2009).","DOI":"10.1002\/dvg.20509"},{"key":"48498_CR29","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s10815-020-01758-x","volume":"37","author":"LG Robinson","year":"2020","unstructured":"Robinson, L. G. et al. Impaired reproductive function and fertility preservation in a woman with a dyskeratosis congenita. Journal of Assisted Reproduction and Genetics 37, 1221\u20131225 (2020).","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"48498_CR30","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/bjh.17545","volume":"193","author":"N Giri","year":"2021","unstructured":"Giri, N., Alter, B. P., Savage, S. A. & Stratton, P. G. Gynaecological and reproductive health of women with telomere biology disorders. British journal of haematology 193, 1238\u20131246 (2021).","journal-title":"British journal of haematology"},{"key":"48498_CR31","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1182\/blood.V124.21.1598.1598","volume":"124","author":"N Giri","year":"2014","unstructured":"Giri, N., Alter, B. P., Savage, S. A. & Stratton, P. Fertility and pregnancy outcomes in females with dyskeratosis congenita. Blood 124, 1598 (2014).","journal-title":"Blood"},{"key":"48498_CR32","doi-asserted-by":"publisher","first-page":"E197","DOI":"10.1210\/jc.2014-2838","volume":"100","author":"MM Sklavos","year":"2015","unstructured":"Sklavos, M. M. et al. Reduced serum levels of anti-m\u00fcllerian hormone in females with inherited bone marrow failure syndromes. The Journal of Clinical Endocrinology & Metabolism 100, E197\u2013E203 (2015).","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"48498_CR33","doi-asserted-by":"publisher","DOI":"10.1530\/EC-23-0510","author":"P Stratton","year":"2024","unstructured":"Stratton, P. et al. Reduced anti-m\u00fcllerian hormone levels in males with inherited bone marrow failure syndromes. Endocr. Connect. https:\/\/doi.org\/10.1530\/EC-23-0510 (2024).","journal-title":"Endocr. Connect."},{"key":"48498_CR34","first-page":"943","volume":"18","author":"MM AlSabbagh","year":"2020","unstructured":"AlSabbagh, M. M. Dyskeratosis congenita: A literature review. JDDG J. Dtsch. Dermatol. Ges. 18, 943\u2013967 (2020).","journal-title":"JDDG J. Dtsch. Dermatol. Ges."},{"key":"48498_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","volume":"24","author":"A Shimamura","year":"2010","unstructured":"Shimamura, A. & Alter, B. P. Pathophysiology and management of inherited bone marrow failure syndromes. Blood reviews 24, 101\u2013122 (2010).","journal-title":"Blood reviews"},{"key":"48498_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/pbc.24617","volume":"61","author":"SR Rose","year":"2014","unstructured":"Rose, S. R. et al. Oxandrolone for the treatment of bone marrow failure in fanconi anemia. Pediatric Blood & Cancer 61, 11\u201319 (2014).","journal-title":"Pediatric Blood & Cancer"},{"key":"48498_CR37","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1056\/NEJM196105112641901","volume":"264","author":"NT Shahidi","year":"1961","unstructured":"Shahidi, N. T. & Diamond, L. K. Testosterone-induced remission in aplastic anemia of both acquired and congenital types: Further observations in 24 cases. New England Journal of Medicine 264, 953\u2013967 (1961).","journal-title":"New England Journal of Medicine"},{"key":"48498_CR38","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","volume":"374","author":"DM Townsley","year":"2016","unstructured":"Townsley, D. M. et al. Danazol treatment for telomere diseases. New England Journal of Medicine 374, 1922\u20131931 (2016).","journal-title":"New England Journal of Medicine"},{"key":"48498_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jmig.2006.06.026","volume":"13","author":"AA Luciano","year":"2006","unstructured":"Luciano, A. A. Danazol treatment of endometriosis-associated pain. J. Minim. Invasive Gynecol. 13, 523\u2013524 (2006).","journal-title":"J. Minim. Invasive Gynecol."},{"key":"48498_CR40","doi-asserted-by":"crossref","unstructured":"Farquhar, C. et al. Danazol for pelvic pain associated with endometriosis. Cochrane Database of Systematic Reviews 2010 (1996).","DOI":"10.1002\/14651858.CD000068.pub2"},{"key":"48498_CR41","first-page":"305","volume":"4","author":"I C\u00f3rdova-Oriz","year":"2023","unstructured":"C\u00f3rdova-Oriz, I. et al. A randomized controlled intervention trial with danazol to improve telomeric and fertility parameters in women with diminished ovarian reserve: a pilot study. Womens Health Rep. 4, 305\u2013318 (2023).","journal-title":"Womens Health Rep."},{"key":"48498_CR42","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1182\/blood-2008-09-178871","volume":"114","author":"RT Calado","year":"2009","unstructured":"Calado, R. T. et al. Sex hormones, acting on the tert gene, increase telomerase activity in human primary hematopoietic cells. Blood 114, 2236\u20132243 (2009).","journal-title":"Blood"},{"key":"48498_CR43","doi-asserted-by":"publisher","first-page":"723","DOI":"10.18632\/aging.100072","volume":"1","author":"A Marciniak-Czochra","year":"2009","unstructured":"Marciniak-Czochra, A., Stiehl, T. & Wagner, W. Modeling of replicative senescence in hematopoietic development. Aging (Albany NY) 1, 723 (2009).","journal-title":"Aging (Albany NY)"},{"key":"48498_CR44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/imammb\/dqaf004","volume":"42","author":"LG Parajdi","year":"2025","unstructured":"Parajdi, L. G., Bai, X., Kegyes, D. & Tomuleasa, C. A mathematical model of clonal hematopoiesis explaining phase transitions in chronic myeloid leukemia. Math. Med. Biol. 42, 253\u2013288 (2025).","journal-title":"Math. Med. Biol."},{"key":"48498_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbs.2024.109305","volume":"377","author":"A Portillo","year":"2024","unstructured":"Portillo, A., Garc\u00eda-Velasco, J. & Varela, E. An in-silico approach to the dynamics of proliferation potential in stem cells and the study of different therapies in cases of ovarian dysfunction. Math. Biosci. 377, 109305. https:\/\/doi.org\/10.1016\/j.mbs.2024.109305 (2024).","journal-title":"Math. Biosci."},{"key":"48498_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107053","author":"C Boyle","year":"2023","unstructured":"Boyle, C., Lansdorp, P. M. & Edelstein-Keshet, L. Predicting the number of lifetime divisions for hematopoietic stem cells from telomere length measurements. iScience https:\/\/doi.org\/10.1016\/j.isci.2023.107053 (2023).","journal-title":"iScience"},{"key":"48498_CR47","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.08687","volume":"4","author":"B Werner","year":"2015","unstructured":"Werner, B. et al. Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributions. Elife 4, e08687 (2015).","journal-title":"Elife"},{"key":"48498_CR48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","volume":"20","author":"S M\u00e9ndez-Ferrer","year":"2020","unstructured":"M\u00e9ndez-Ferrer, S. et al. Bone marrow niches in haematological malignancies. Nat. Rev. Cancer 20, 285\u2013298 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"48498_CR49","doi-asserted-by":"crossref","unstructured":"Wang, Y.-X. et al. Function of hematopoiesis and bone marrow niche in inflammation and non-hematopoietic diseases. Life Medicine 4, lnaf015 (2025).","DOI":"10.1093\/lifemedi\/lnaf015"},{"key":"48498_CR50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/ajh.27162","volume":"99","author":"L Oberholzer","year":"2024","unstructured":"Oberholzer, L. et al. Determinants and reference values for blood volume and total hemoglobin mass in women and men. Am. J. Hematol. 99, 88\u201398 (2024).","journal-title":"Am. J. Hematol."},{"key":"48498_CR51","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1365-2141.2009.07598.x","volume":"145","author":"AJ Walne","year":"2009","unstructured":"Walne, A. J. & Dokal, I. Advances in the understanding of dyskeratosis congenita. Br. J. Haematol. 145, 164\u2013172 (2009).","journal-title":"Br. J. Haematol."},{"key":"48498_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15406\/jcpcr.2017.07.00251","volume":"7","author":"P Singh","year":"2017","unstructured":"Singh, P., Sinha, A., Kamath, A., Malhotra, S. & Chandra, A. Aplastic anemia-a quick review. J. Cancer Prev. Curr. Res. 7, 1\u20136 (2017).","journal-title":"J. Cancer Prev. Curr. Res."},{"key":"48498_CR53","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/152873901753215911","volume":"64","author":"S Haddad","year":"2001","unstructured":"Haddad, S., Restieri, C. & Krishnan, K. Characterization of age-related changes in body weight and organ weights from birth to adolescence in humans. J. Toxicol. Environ. Health A. 64, 453\u2013464 (2001).","journal-title":"J. Toxicol. Environ. Health A."},{"key":"48498_CR54","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.it.2021.10.006","volume":"42","author":"J Cosgrove","year":"2021","unstructured":"Cosgrove, J., Hustin, L. S., de Boer, R. J. & Peri\u00e9, L. Hematopoiesis in numbers. Trends Immunol. 42, 1100\u20131112 (2021).","journal-title":"Trends Immunol."},{"key":"48498_CR55","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1651-2227.1988.tb10751.x","volume":"77","author":"S Hreidarsson","year":"1988","unstructured":"Hreidarsson, S., Kristjansson, K., Johannesson, G. & Johannsson, J. A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure. Acta Paediatr. 77, 773\u2013775 (1988).","journal-title":"Acta Paediatr."},{"key":"48498_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1651-2227.1970.tb08986.x","volume":"59","author":"HM H\u00f8Yeraal","year":"1970","unstructured":"H\u00f8Yeraal, H. M., Lamvik, J. & Moe, P. J. Congenital hypoplastic thrombocytopenia and cerebral malformations in two brothers. Acta Paediatr. 59, 185\u2013191 (1970).","journal-title":"Acta Paediatr."},{"key":"48498_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1046\/j.1365-2141.1999.01690.x","volume":"107","author":"S Knight","year":"1999","unstructured":"Knight, S. et al. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (hoyeraal-hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, dkc1. Br. J. Haematol. 107, 335\u2013339 (1999).","journal-title":"Br. J. Haematol."},{"key":"48498_CR58","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jmg.29.9.673","volume":"29","author":"T Revesz","year":"1992","unstructured":"Revesz, T., Fletcher, S., Al-Gazali, L. & DeBuse, P. Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: A new syndrome?. J. Med. Genet. 29, 673\u2013675 (1992).","journal-title":"J. Med. Genet."},{"key":"48498_CR59","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13023-020-01553-y","volume":"15","author":"M Karremann","year":"2020","unstructured":"Karremann, M. et al. Revesz syndrome revisited. Orphanet J. Rare Dis. 15, 299 (2020).","journal-title":"Orphanet J. Rare Dis."},{"key":"48498_CR60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2201662119","volume":"119","author":"JC Zinder","year":"2022","unstructured":"Zinder, J. C. et al. Shelterin is a dimeric complex with extensive structural heterogeneity. Proc. Natl. Acad. Sci. U. S. A. 119, e2201662119 (2022).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"48498_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/24741264221129430","volume":"7","author":"AE Sears","year":"2023","unstructured":"Sears, A. E., Awh, C. C., Kunhiabdullah, S., Sears, J. E. & Mammo, D. A. Coats plus syndrome in a premature infant, with a focus on management. J. Vitreoretin. Dis. 7, 74\u201378 (2023).","journal-title":"J. Vitreoretin. Dis."},{"key":"48498_CR62","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/13816810.2020.1772315","volume":"41","author":"E Han","year":"2020","unstructured":"Han, E. et al. A unique case of coats plus syndrome and dyskeratosis congenita in a patient with ctc1 mutations. Ophthalmic Genet. 41, 363\u2013367 (2020).","journal-title":"Ophthalmic Genet."},{"key":"48498_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-genet-032918-021921","volume":"52","author":"T de Lange","year":"2018","unstructured":"de Lange, T. Shelterin-mediated telomere protection. Annu. Rev. Genet. 52, 223\u2013247 (2018).","journal-title":"Annu. Rev. Genet."},{"key":"48498_CR64","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1101\/gad.276873.115","volume":"30","author":"H Takai","year":"2016","unstructured":"Takai, H. et al. A pot1 mutation implicates defective telomere end fill-in and telomere truncations in coats plus. Genes & Development 30, 812\u2013826 (2016).","journal-title":"Genes & Development"},{"key":"48498_CR65","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/S0140-6736(03)14797-6","volume":"362","author":"PF Fogarty","year":"2003","unstructured":"Fogarty, P. F. et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet 362, 1628\u20131630 (2003).","journal-title":"Lancet"},{"key":"48498_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024383","volume":"6","author":"TJ Vulliamy","year":"2011","unstructured":"Vulliamy, T. J. et al. Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations. PLoS One 6, e24383 (2011).","journal-title":"PLoS One"},{"key":"48498_CR67","first-page":"309","volume":"113","author":"H-Y Du","year":"2009","unstructured":"Du, H.-Y. et al. Terc and tert gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood, The Journal of the American Society of Hematology 113, 309\u2013316 (2009).","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"48498_CR68","first-page":"1674","volume":"130","author":"N Giri","year":"2017","unstructured":"Giri, N., Stratton, P., Savage, S. A. & Alter, B. P. Pregnancies in patients with inherited bone marrow failure syndromes in the nci cohort. Blood, The Journal of the American Society of Hematology 130, 1674\u20131676 (2017).","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"48498_CR69","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/0974-1208.142475","volume":"7","author":"YB Jeve","year":"2014","unstructured":"Jeve, Y. B. & Davies, W. Evidence-based management of recurrent miscarriages. Journal of human reproductive sciences 7, 159\u2013169 (2014).","journal-title":"Journal of human reproductive sciences"},{"key":"48498_CR70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1341-8076.2002.00077.x","volume":"29","author":"D Deka","year":"2003","unstructured":"Deka, D. et al. Pregnancy associated aplastic anemia: maternal and fetal outcome. Journal of obstetrics and gynaecology research 29, 67\u201377 (2003).","journal-title":"Journal of obstetrics and gynaecology research"},{"key":"48498_CR71","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7326\/0003-4819-137-3-200208060-00008","volume":"137","author":"A Tichelli","year":"2002","unstructured":"Tichelli, A. et al. Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression. Annals of internal medicine 137, 164\u2013172 (2002).","journal-title":"Annals of internal medicine"},{"key":"48498_CR72","first-page":"1671","volume":"130","author":"JM Gansner","year":"2017","unstructured":"Gansner, J. M. et al. Pregnancy outcomes in inherited bone marrow failure syndromes. Blood, The Journal of the American Society of Hematology 130, 1671\u20131674 (2017).","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"48498_CR73","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2011.055269","volume":"97","author":"BP Alter","year":"2012","unstructured":"Alter, B. P. et al. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica 97, 353 (2012).","journal-title":"Haematologica"},{"key":"48498_CR74","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/01.ju.0000074653.22766.c8","volume":"170","author":"C Guo","year":"2003","unstructured":"Guo, C., Armbruster, B. N., Price, D. T. & Counter, C. M. In vivo regulation of htert expression and telomerase activity by androgen. The Journal of urology 170, 615\u2013618 (2003).","journal-title":"The Journal of urology"},{"key":"48498_CR75","doi-asserted-by":"crossref","unstructured":"Bernardes de Jesus, B. et al. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO molecular medicine 4, 691\u2013704 (2012).","DOI":"10.1002\/emmm.201200245"},{"key":"48498_CR76","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S0140-6736(16)00416-5","volume":"387","author":"J Collins","year":"2016","unstructured":"Collins, J., Tummala, H., Collopy, L., Vulliamy, T. & Dokal, I. In-vitro analysis of the effects of ta65 and danazol on the proliferation and telomerase activity of t lymphocytes in bone marrow failure syndromes. Lancet 387, S29 (2016).","journal-title":"Lancet"},{"key":"48498_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.70107","volume":"13","author":"HT Nurelegne","year":"2025","unstructured":"Nurelegne, H. T. et al. Germline parn variants in telomere biology disorders and challenges in variant curation. Mol. Genet. Genomic Med. 13, e70107 (2025).","journal-title":"Mol. Genet. Genomic Med."},{"key":"48498_CR78","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.gde.2005.04.004","volume":"15","author":"A Marrone","year":"2005","unstructured":"Marrone, A., Walne, A. & Dokal, I. Dyskeratosis congenita: Telomerase, telomeres and anticipation. Curr. Opin. Genet. Dev. 15, 249\u2013257 (2005).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"48498_CR79","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1242\/dev.106575","volume":"141","author":"A Nakamura-Ishizu","year":"2014","unstructured":"Nakamura-Ishizu, A., Takizawa, H. & Suda, T. The analysis, roles and regulation of quiescence in hematopoietic stem cells. Development 141, 4656\u20134666 (2014).","journal-title":"Development"},{"key":"48498_CR80","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1083\/jcb.201610111","volume":"216","author":"P Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez, P. & Blasco, M. A. Telomere-driven diseases and telomere-targeting therapies. J. Cell Biol. 216, 875\u2013887 (2017).","journal-title":"J. Cell Biol."},{"key":"48498_CR81","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/MOH.0000000000000644","volume":"28","author":"D Loeffler","year":"2021","unstructured":"Loeffler, D. & Schroeder, T. Symmetric and asymmetric activation of hematopoietic stem cells. Curr. Opin. Hematol. 28, 262\u2013268 (2021).","journal-title":"Curr. Opin. Hematol."},{"key":"48498_CR82","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0092-8674(01)00504-9","volume":"107","author":"MT Hemann","year":"2001","unstructured":"Hemann, M. T., Strong, M. A., Hao, L.-Y. & Greider, C. W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67\u201377 (2001).","journal-title":"Cell"},{"key":"48498_CR83","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1038\/ncomms6863","volume":"5","author":"C B\u00e4r","year":"2014","unstructured":"B\u00e4r, C. et al. Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction. Nat. Commun. 5, 5863 (2014).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48498-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48498-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48498-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:03:11Z","timestamp":1786626191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48498-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48498"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48498-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25270"}}